IL2 and cancer: These antitumor roles of CD4+ Th1 cells are mainly driven by the triad of cytokines, such as IFN-γ, TNF-α and IL-2.5,6 Furthermore, a clinical benefit associated with Th1-polarised signature in the TME has been reported in many human cancers.13